BIOPTERIN, CATECHOLAMINES, & NO IN REGULATING APOPTOSIS
生物蝶呤、儿茶酚胺、
基本信息
- 批准号:6407212
- 负责人:
- 金额:$ 3.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-28 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) Dopamine neurons in the
substantia nigra die prematurely in Parkinson's disease, and apoptotic death
has been detected postmortem. The cause of apoptosis is unknown. Two prominent,
yet unsubstantiated hypotheses are that apoptosis is mediated by oxidative
stress or inappropriate reentry into the cell cycle; both conditions may be
initiated by insufficient neurotrophic support from striatal target cells. We
will address this knowledge gap by studying mechanisms underlying apoptosis in
cultured catecholamine cells, where conditions can me more tightly controlled
than in animals. Cells to be studied include pheochromocytoma (PC12),
sympathetic neurons, and fetal nigral neurons. These models have in vivo
relevance, since apoptotic death of nigral dopamine neurons during development
may be due to insufficient trophic support from striatal target cells; this
mechanism has been suggested as a causal cell death factor in Parkinson's
disease. Tetrahydrobiopterin (BH4) is an essential regulatory cofactor for
tyrosine hydroxylase and nitric oxide (NO) synthase in the synthesis of
catecholamines and NO, which will not occur if BH4 is lacking. Catecholamine
cells contain among the highest concentrations of BH4. The metabolism of BH4,
catecholamines, and NO can generate damaging reactive oxygen species (ROS). Our
preliminary data shows that apoptotic death of differentiated neuron-like PC12
cells during nerve growth factor withdrawal is directly proportional to the
intracellular level of BH4. Thus, we hypothesize that the endogenous level of
BH4 supports catecholamine cell functions under normal conditions and promotes
apoptotic death when trophic support is withdrawn. Our working hypothesis and
specific aim is: Intracellular BH4 mediates apoptosis and death of
catecholamine cells deprived of trophic support. While the complex processes of
apoptosis occur in many cell types, we will focus on catecholamine cells and
the direct and indirect interactions of BH4 with pivotal mediators of apoptosis
of these cells during insufficient trophic support.
These mediators include oxidative stress, oncogenes that can initiate fatal
reentry into the cell cycle, and critical cysteine proteases (caspases)
mediating apoptosis. Our studies will identify the mechanism of BH4 involvement
in apoptosis by testing for: 1) elevation of ROS and the source (BH4,
catecholamines, or NO); 2) altered expression of the apoptotic-mediating
oncogenes, pS3, c-myc, and the bc1-2 family (bax, bak, bc1-2, bcl-xl), and 3)
activation of caspases 2,3, and 9. Apoptosis will be monitored by: a) number of
living and dead cells; and b) fluorescent quantitation of cells at different
stages of apoptosis.
These studies may will reveal novel apoptotic regulatory mechanisms and provide
new avenues for therapeutic approaches to promote neuronal survival and prevent
debilitating neurological diseases, such as Parkinson's disease.
描述:(逐字来自申请人的摘要)
帕金森病患者黑质过早死亡,
是在死后发现的细胞凋亡的原因尚不清楚。两个突出的,
然而,未经证实的假设是,细胞凋亡是由氧化介导的,
压力或不适当的重新进入细胞周期;这两种情况都可能是
由纹状体靶细胞的神经营养支持不足引发。我们
将通过研究细胞凋亡的潜在机制来解决这一知识缺口,
培养的儿茶酚胺细胞,在那里条件可以更严格地控制,
比在动物身上。待研究的细胞包括嗜铬细胞瘤(PC 12),
交感神经元和胎儿黑质神经元。这些模型在体内
相关性,因为在发育过程中黑质多巴胺神经元的凋亡性死亡
可能是由于纹状体靶细胞的营养支持不足;这
在帕金森氏症中,这种机制被认为是导致细胞死亡的因素。
疾病四氢生物蝶呤(BH 4)是一种重要的调节辅因子,
酪氨酸羟化酶和一氧化氮(NO)合酶在合成
儿茶酚胺和NO,如果缺乏BH 4,则不会发生。儿茶酚胺
细胞中含有最高浓度的BH 4。BH 4的代谢,
儿茶酚胺和NO可以产生破坏性的活性氧(ROS)。我们
初步数据显示分化的神经元样PC 12的凋亡性死亡
在神经生长因子撤退期间的细胞是成正比的,
细胞内BH 4水平。因此,我们假设,
BH 4在正常条件下支持儿茶酚胺细胞功能,
当营养支持被撤销时细胞凋亡。我们的工作假设和
具体目的是:细胞内BH 4介导细胞凋亡和死亡
缺乏营养支持的儿茶酚胺细胞。虽然复杂的过程,
凋亡发生在许多细胞类型中,我们将重点关注儿茶酚胺细胞,
BH 4与细胞凋亡关键介质的直接和间接相互作用
在营养支持不足的情况下,这些细胞的生长。
这些介质包括氧化应激,致癌基因,可以启动致命的
重新进入细胞周期,和关键的半胱氨酸蛋白酶(半胱天冬酶)
介导细胞凋亡。我们的研究将确定BH 4参与的机制
通过测试:1)ROS的升高和源(BH 4,
儿茶酚胺,或NO); 2)改变表达的促肾上腺皮质激素介导的
癌基因,pS3,c-myc,和bc 1 -2家族(bax,巴克,bc 1 -2,bcl-xl),和3)
半胱天冬酶2、3和9的活化。将通过以下方式监测细胞凋亡:
活细胞和死细胞;和B)在不同温度下对细胞进行荧光定量
凋亡的阶段。
这些研究可能会揭示新的凋亡调控机制,
治疗方法的新途径,以促进神经元存活和预防
使人衰弱的神经系统疾病,如帕金森病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT A LEVINE其他文献
ROBERT A LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT A LEVINE', 18)}}的其他基金
The role of Federal legislation on breast cancer disparities
联邦立法对乳腺癌差异的作用
- 批准号:
8374988 - 财政年份:2011
- 资助金额:
$ 3.64万 - 项目类别:
The role of Federal legislation on breast cancer disparities
联邦立法对乳腺癌差异的作用
- 批准号:
7685244 - 财政年份:2009
- 资助金额:
$ 3.64万 - 项目类别:
Conference on Complementary and Alternative Medicine
补充和替代医学会议
- 批准号:
7095601 - 财政年份:2005
- 资助金额:
$ 3.64万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
7784799 - 财政年份:2003
- 资助金额:
$ 3.64万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
8420189 - 财政年份:2003
- 资助金额:
$ 3.64万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
8197425 - 财政年份:2003
- 资助金额:
$ 3.64万 - 项目类别:
Effect of Mitral Regurgitation on Ischemic LV Remodeling
二尖瓣反流对缺血性左室重构的影响
- 批准号:
6862312 - 财政年份:2003
- 资助金额:
$ 3.64万 - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 3.64万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 3.64万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 3.64万 - 项目类别:
Studentship
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Grant-in-Aid for JSPS Fellows
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Operating Grants
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Research Grant
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 3.64万 - 项目类别:
Studentship